1. Home
  2. GAUZ vs PRQR Comparison

GAUZ vs PRQR Comparison

Compare GAUZ & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GAUZ
  • PRQR
  • Stock Information
  • Founded
  • GAUZ 2009
  • PRQR 2012
  • Country
  • GAUZ Israel
  • PRQR Netherlands
  • Employees
  • GAUZ N/A
  • PRQR N/A
  • Industry
  • GAUZ Industrial Machinery/Components
  • PRQR Biotechnology: Pharmaceutical Preparations
  • Sector
  • GAUZ Miscellaneous
  • PRQR Health Care
  • Exchange
  • GAUZ Nasdaq
  • PRQR Nasdaq
  • Market Cap
  • GAUZ 180.1M
  • PRQR 179.1M
  • IPO Year
  • GAUZ 2024
  • PRQR 2014
  • Fundamental
  • Price
  • GAUZ $8.61
  • PRQR $2.04
  • Analyst Decision
  • GAUZ Strong Buy
  • PRQR Strong Buy
  • Analyst Count
  • GAUZ 4
  • PRQR 8
  • Target Price
  • GAUZ $15.50
  • PRQR $8.88
  • AVG Volume (30 Days)
  • GAUZ 25.2K
  • PRQR 355.0K
  • Earning Date
  • GAUZ 08-07-2025
  • PRQR 08-07-2025
  • Dividend Yield
  • GAUZ N/A
  • PRQR N/A
  • EPS Growth
  • GAUZ N/A
  • PRQR N/A
  • EPS
  • GAUZ N/A
  • PRQR N/A
  • Revenue
  • GAUZ $101,165,000.00
  • PRQR $21,212,711.00
  • Revenue This Year
  • GAUZ $28.49
  • PRQR N/A
  • Revenue Next Year
  • GAUZ $47.77
  • PRQR N/A
  • P/E Ratio
  • GAUZ N/A
  • PRQR N/A
  • Revenue Growth
  • GAUZ 18.63
  • PRQR 85.91
  • 52 Week Low
  • GAUZ $6.78
  • PRQR $1.07
  • 52 Week High
  • GAUZ $13.00
  • PRQR $4.62
  • Technical
  • Relative Strength Index (RSI)
  • GAUZ N/A
  • PRQR 71.54
  • Support Level
  • GAUZ N/A
  • PRQR $1.89
  • Resistance Level
  • GAUZ N/A
  • PRQR $2.20
  • Average True Range (ATR)
  • GAUZ 0.00
  • PRQR 0.11
  • MACD
  • GAUZ 0.00
  • PRQR 0.02
  • Stochastic Oscillator
  • GAUZ 0.00
  • PRQR 90.70

About GAUZ Gauzy Ltd. Ordinary Shares

Gauzy Ltd is a fully integrated light and vision control company. Its products include suspended particle device and liquid crystal materials for smart glass applications and AI-powered driver assistance systems, or ADAS, solutions including camera monitoring systems. The company's operating segments are Architecture, Automotive, Safety tech, and Aeronautics. Maximum revenue is generated from its Safety tech segment, which focuses on sales of driver assistance systems for buses, coaches, recreational vehicles, and specific vehicles, such as camera and motion sensor systems, smart mirrors, and safety doors. Geographically, it derives maximum revenue from other European countries (excluding France), followed by the United States, France, Asia, Israel, and other regions.

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.

Share on Social Networks: